中美传染病防治药物储备现状比较与展望  

Comparison and prospect of drug stockpiling for infectious disease prevention and treatment between China and the United States

作　　者：宋亚彬 赵晓冬[1] 王保刚 赵瑾 SONG Yabin;ZHAO Xiaodong;WANG Baogang;ZHAO Jin(Academy of Military Medical Sciences,Academy of Military Sciences,Beijing 100071,China)

机构地区：[1]军事科学院军事医学研究院,北京100071

出　　处：《军事医学》2024年第7期543-548,共6页Military Medical Sciences

摘　　要：近年来,重大传染病疫情引发公共卫生事件,给全球人类健康与经济社会发展带来深远影响。做好传染病防治药物储备对提升公共卫生事件应对能力具有重要意义和作用。当前我国传染病防治药物储备体系仍有待完善之处。该文比较了中美传染病防治药物储备发展状况,结合我国当前实际,提出对策建议,以期为提高我国传染病防治药物储备水平提供参考。In recent years,public health events caused by severe infectious diseases had a profound impact on human health,economic and social development.Drug stockpiling for infectious disease prevention and treatment is of great significance in improving the ability to respond to public health events.However,the drug stockpiling system of China for infectious disease prevention and treatment still needs to be improved.Based on the investigation and comparison of the current status of drug stockpiling for infectious disease prevention and treatment between China and the United States,this article proposes some suggestions according to China′s specific circumstances for reference.

关 键 词：传染病防治药物 储备 公共卫生事件 疫情防控 比较 

分 类 号：R954[医药卫生—药学]